D'fhéadfadh ailse scamhóige dul i bhfeidhm ar dhuine ar bith, ach d'fhéadfadh fachtóirí áirithe an baol a bhaineann leis an galar a fhorbairt a mhéadú.
Áirítear leo seo a leanas:
1. Caitheamh tobac: Is é caitheamh tobac an phríomhchúis do ailse scamhóg.
An níos faide a chaitheann duine tobac agus an níos mó tobac a chaitheann siad, an níos mó riosca a bhíonn acu.
2. Caitheamh tobac ó dhaoine eile: Is féidir le nochtadh do chaitheamh tobac ó dhaoine eile an baol ailse scamhóg a mhéadú freisin.
3. Gás radón: Is féidir le nochtadh do ghás radón, gáis radaighníomhach a tharlaíonn go nádúrtha is féidir a chruinniú i dtithe, an baol ailse scamhóige a mhéadú.
4. Asbestos agus carcinogens eile: Is féidir le nochtadh d'asbestos, arsenic, cróimiam, nicil, agus substaintí eile an baol ailse scamhóg a mhéadú.
5. truailliú aeir: Is féidir le nochtadh fadtéarmach do thruailliú aeir an baol ailse scamhóg a mhéadú.
6. Stair theaghlaigh: D'fhéadfadh stair theaghlaigh de ailse scamhóige riosca duine a mhéadú.
7. Aois: Méadaíonn an baol go dtarlóidh ailse scamhóg leis an aois, agus tarlaíonn an chuid is mó de na cásanna i ndaoine os cionn 65 bliain d'aois.
8. Gnéas: Tá fir níos dóchúla ailse scamhóige a fhorbairt ná mná.
9. Stair pheata pearsanta: D'fhéadfadh go mbeadh riosca méadaithe ailse scamhóige ag daoine a bhfuil stair ghalar scamhóige acu mar galar scamhóige obstrutive ainsealach (COPD) nó tobac.
10. Teiripe radaíochta chuig an gcraiceann: Tá riosca méadaithe ailse scamhóige ag daoine a ndearnadh teiripe radaíochta chuig an gcraiceann le haghaidh ailse eile.
Tá sé tábhachtach a thabhairt faoi deara nach ndéanfaidh gach duine a bhfuil fachtóirí riosca acu ailse scamhóige a fhorbairt, agus d'fhéadfadh nach mbeadh aon fachtóirí riosca ar eolas ag roinnt daoine a d'fhorbair ailse scamhóige.
Couraud S, Grolleau E: [How to implement lung cancer screening ?] Rev Prat. 2020, 70 (8): 864-867.
Casutt A, Lovis A, Selby K, Noirez L, Peters S, Beigelman-Aubry C, Krueger T, Soccal PM, Von Garnier C: [Lung cancer screening in Switzerland : Who ? How ? When ?] Rev Med Suisse. 2020, 16 (715): 2224-2226.
Peres J: Lung cancer screening gets risk-specific. J Natl Cancer Inst. 2013, 105 (1): 1-2.
McNeil C: Combined therapy for lung cancer gets a boost. J Natl Cancer Inst. 1996, 88 (17): 1182-4.
Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Grimaud E, Labbe M, Contesso G, Le M: Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment. Breast Cancer Res Treat. 2002, 75 (1): 15-24.
Ali Mohammed Hammamy R, Farooqui K, Ghadban W: Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma. Case Rep Med. 2018, 2018 (): 1903757.
Wu J, Ma L, Wang J, Qiao Y: [Mechanism of Ferroptosis and Its Research Progress in Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2020, 23 (9): 811-817.
Cancer Screening Gets Thumbs-up From Readers. Manag Care. 2017, 26 (5): 30-31.
Diúltú freagrachta: leighis
Cuirtear an suíomh gréasáin seo ar fáil chun críocha oideachais agus faisnéise amháin agus ní sholáthraíonn sé comhairle leighis nó seirbhísí gairmiúla.
Níor cheart an t-eolas a chuirtear ar fáil a úsáid chun fadhb sláinte nó galar a dhiagnóisiú nó a chóireáil, agus ba cheart dóibh siúd atá ag lorg comhairle leighis phearsanta dul i gcomhairle le dochtúir ceadúnaithe.
Tabhair faoi deara le do thoil go bhfuil an líonra néarónach a ghineann freagraí ar na ceisteanna, míchruinn go háirithe nuair a bhaineann sé le hábhar uimhriúil. Mar shampla, líon na ndaoine a ndearnadh diagnóis orthu le galar ar leith.
Déan comhairle do dhochtúir nó do sholáthraí sláinte cáilithe eile i gcónaí maidir le riocht leighis. Ná déan neamhaird ar chomhairle leighis ghairmiúil ná déileáil leis mar gheall ar rud éigin a léigh tú ar an suíomh Gréasáin seo. Má cheapann tú go bhféadfadh éigeandáil leighis a bheith agat, glaoigh ar 911 nó téigh go dtí an seomra éigeandála is gaire láithreach. Ní chruthaíonn an suíomh Gréasáin seo ná a úsáid aon chaidreamh dochtúir-othar. Ní dhéanann BioMedLib ná a chuid fostaithe, ná aon ranníocóir leis an suíomh Gréasáin seo aon ionadaíochtaí, sainráite nó intuigthe, maidir leis an bhfaisnéis a sholáthraítear anseo ná a úsáid.
Diúltú freagrachta: cóipchirt
Soláthraíonn an Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (an DMCA) aisíocaíocht do úinéirí cóipchirt a chreideann go sáraíonn ábhar atá le feiceáil ar an Idirlíon a gcearta faoi dhlí cóipchirt na Stát Aontaithe.
Má chreideann tú go dea-chreidimh go sáraíonn aon ábhar nó ábhar a chuirtear ar fáil i ndáil lenár suíomh Gréasáin nó lenár seirbhísí do chóipcheart, féadfaidh tú (nó do ghníomhaire) fógra a sheoladh chugainn ag iarraidh an t-ábhar nó an t-ábhar a bhaint, nó rochtain air a bhac.
Ní mór fógraí a sheoladh i scríbhinn trí ríomhphost (féach an rannán "Contact" le haghaidh seoladh ríomhphoist).
Éilíonn an DMCA go gcuimsíonn do fhógra faoi shárú cóipchirt líomhain an fhaisnéis seo a leanas: (1) cur síos ar an saothar cóipchirt atá ina ábhar don shárú líomhain; (2) cur síos ar an ábhar líomhain atá ag sárú líomhain agus faisnéis leordhóthanach chun ligean dúinn an t-ábhar a aimsiú; (3) faisnéis teagmhála duit, lena n-áirítear do sheoladh, uimhir theileafóin agus seoladh ríomhphoist; (4) ráiteas uait go bhfuil creideamh maith agat nach bhfuil an t-ábhar ar an mbealach a bhfuil gearán á dhéanamh air údaraithe ag úinéir cóipchirt, nó a ghníomhaire, nó ag oibriú aon dlí;
(5) ráiteas uait, arna shíniú faoi phionós perjury, go bhfuil an t-eolas sa fhógra cruinn agus go bhfuil an t-údarás agat na cóipchearta a éilítear a shárú a fhorfheidhmiú;
agus (6) síntiús fisiciúil nó leictreonach úinéir an chóipchirt nó duine údaraithe chun gníomhú thar ceann úinéir an chóipchirt.
D'fhéadfadh moill a bheith ar phróiseáil do ghearán mura gcuirfidh tú an t-eolas thuas go léir san áireamh.
Cumarsáid
Seol ríomhphost dúinn le haon cheist / moladh le do thoil.
Who gets lung cancer?
Lung cancer can affect anyone, but certain factors can increase the risk of developing the disease.
These include:
1. Smoking: Smoking is the leading cause of lung cancer.
The longer a person smokes and the more cigarettes they smoke, the greater their risk.
2. Secondhand smoke: Exposure to secondhand smoke can also increase the risk of lung cancer.
3. Radon gas: Exposure to radon gas, a naturally occurring radioactive gas that can accumulate in homes, can increase the risk of lung cancer.
4. Asbestos and other carcinogens: Exposure to asbestos, arsenic, chromium, nickel, and other substances can increase the risk of lung cancer.
5. Air pollution: Long-term exposure to air pollution can increase the risk of lung cancer.
6. Family history: A family history of lung cancer may increase a person's risk.
7. Age: The risk of lung cancer increases with age, with most cases occurring in people over the age of 65.
8. Gender: Men are more likely to develop lung cancer than women.
9. Personal history of lung disease: People with a history of lung diseases such as chronic obstructive pulmonary disease (COPD) or tuberculosis may have an increased risk of lung cancer.
10. Radiation therapy to the chest: People who have had radiation therapy to the chest for other cancers have an increased risk of lung cancer.
It is important to note that not everyone with risk factors will develop lung cancer, and some people who do develop lung cancer may not have any known risk factors.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Timpeall
Úsáideann BioMedLib ríomhairí uathoibrithe (algorithms foghlama meaisín) chun péirí ceisteanna agus freagraí a ghiniúint.
Tosaímid le 35 milliún foilseachán bithleighis de PubMed/Medline. Chomh maith le leathanaigh ghréasáin de RefinedWeb.
